Furazolidone

CHEMBL1103 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
225.2 g/mol
LogP
-0.1
Phase
4

This nitrofuran antibiotic and antiprotozoal medication treats bacterial and parasitic intestinal infections including giardiasis and cholera by generating toxic free radicals inside susceptible microorganisms. It has also been studied for its activity against Helicobacter pylori.

น้ำหนักโมเลกุล

225.1600 g/mol

LogP

-0.10

TPSA

101.00 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1

InChI

InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+

Molecular Formula

C8H7N3O5

HBD / HBA

- / 6

พันธะที่หมุนได้

2

อะตอมหนัก

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This nitrofuran antibiotic and antiprotozoal medication treats bacterial and parasitic intestinal infections including giardiasis and cholera by generating toxic free radicals inside susceptible microorganisms. It has also been studied for its activity against Helicobacter pylori.

Yes, Furazolidone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1103. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5323714. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.